Martin Works His Magic Again In KaleBios Pharma Inc.

by Joel Elconin, Benzinga Staff Writer

November 20, 2015 12:02 PM | 1 min read | Make a Comment

KaleBios Pharma Inc.

KBIO

are trading higher by $9 at $19.40 in Friday's session. One day after announing at huge stake in the struggling company, Martin Shkreil has been named as CEO. After a $3 plus higher open, it retreated only $0.49 to to $13.50 before taking flight. So far, it has reached $23.11 before falling back under $20. In the frenzied premarket trading on Thursday, the issue peaked at $24.83 before ending the session at $10.30.

Joel Elconin is the co-host of Benzinga;s #PreMarket Prep, a daily trading idea radio show.

Do you like this article? Do you have suggestions for improvement? Please email feedback@benzinga.com.

Market News and Data brought to you by Benzinga APIs

Posted In: Technicals Intraday Update Movers Trading Ideas Premarket outlook

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!